Additionally, hydroxysteroid (17- beta) dehydrogenase 13 (Hsd17b13) is a key member of the 17β-hydroxysteroid dehydrogenase (HSD17B) family and is highly expressed in nonalcoholic fatty liver disease. Here, HSD17B13 is linked to metabolic dysfunction-associated steatotic liver disease.